Key result
Adult ECMO use expands rapidly for respiratory and cardiac failure despite outpacing current clinical evidence.
Why the study?
Use of extracorporeal membrane oxygenation (ECMO) in adults is rapidly expanding worldwide, yet clinical use outpaces the supporting evidence for many current and potential applications.
This review highlights the rapid growth and expanding indications of ECMO in adults with cardiopulmonary disease, emphasizing the need for more robust evidence to support its use.
No takes yet. Share an insight, caveat, or question.
Clinicians should exercise caution expanding ECMO indications; leaves open key questions requiring rigorous randomized trials to inform practice.
Abrams et al. (2014) conducted a review in Respiratory and cardiac failure. Extracorporeal membrane oxygenation (ECMO) was evaluated. Extracorporeal membrane oxygenation (ECMO) for respiratory and cardiac failure in adults is experiencing rapid growth and expanding indications, though its clinical use currently outpaces the evidence.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: